What Does GE HealthCare (GEHC) Do? – Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters at a Glance
GE HealthCare (GEHC) is a global medical imaging, ultrasound, patient monitoring, and contrast media solutions company. Headquartered in the US, the stock is distinguished by its broad medical device portfolio, expanding AI-driven imaging diagnostics, and the resulting patterns in its share price, outlook, earnings, market cap, revenue, and related stocks.
🏢 What kind of company is GE HealthCare?
GE HealthCare is a global medical device company spun off from General Electric in 2023 and headquartered in Chicago, USA. It operates medical imaging, ultrasound, patient monitoring, and contrast media businesses. The business unit had a long history prior to the spin-off and, since becoming an independent listed company, it has been pursuing the global medical device market.
Its core offerings span a broad medical device portfolio, including diagnostic imaging equipment for computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, and nuclear medicine, as well as patient care solutions such as patient monitoring, ventilators, and anesthesia machines, and contrast media and diagnostic pharmaceuticals.
💰 How does GE HealthCare make money?
| Business Segment | Revenue Share | Description |
|---|---|---|
| Medical Imaging | Core | CT, MRI, X-ray, and nuclear medicine imaging equipment |
| Advanced Visualization & Ultrasound | Key Growth Driver | Ultrasound, cardiovascular, and surgical visualization solutions |
| Patient Care & Contrast Media | Supplementary Business | Patient monitoring, ventilators, contrast media, and diagnostic pharmaceuticals |
Medical imaging accounts for a large share of GE HealthCare's revenue, with a balanced mix of capital equipment sales to global hospitals and diagnostic centers and recurring service and consumables revenue. By segment, medical imaging forms a stable foundation, while advanced visualization and ultrasound serve as the growth axis, driven by expanded cardiovascular and surgical visualization solutions. The contrast media and diagnostic pharmaceuticals segment tracks with imaging diagnostics utilization and provides a recurring revenue structure. The global hospital capital investment cycle and the recovery in medical demand are the main variables driving revenue fluctuations.
📐 GE HealthCare Market Cap and Company Scale
The market cap is $31.8B and the employee count is 54,000명.
GE HealthCare ranks among the top global medical device groups by market capitalization and is benchmarked against peer global medical device and diagnostics groups MDT, BDX, and SYK. In imaging diagnostics, it forms one of the two leading global duopolies. Capital returns follow a balanced approach combining quarterly dividends with share buybacks. Since the spin-off, the company has progressively improved its debt structure and recovered its free cash flow.
📈 GE HealthCare Outlook and Stock Price Trends
Short-term variables include the global hospital capital investment cycle, the pace of recovery in the China healthcare market, and currency fluctuations. Medium- to long-term growth drivers can be summarized in three points. First, the expansion of AI-based imaging diagnostic solutions and a rising share of software and services revenue. Second, the steady expansion of recurring-revenue businesses such as patient monitoring and contrast media. Third, increased imaging diagnostics demand driven by the expansion of medical infrastructure in emerging markets. Sources of potential volatility include the global hospital capital spending cycle, policy changes in the China healthcare market, share competition with peer global medical device groups, and shifts in the global supply chain and tariff environment.
- AI-based imaging diagnostic solutions
- Recurring revenue from contrast media and consumables
- Expansion of medical infrastructure in emerging markets
⚔️ GE HealthCare Key Strengths and Risks
Its strengths lie in a broad medical imaging portfolio and a global sales and service network, while capital spending cycles and currency fluctuations represent its risks.
💪 Key Strengths
⚠️ Key Risks
🔄 GE HealthCare Competitors and Related (Beneficiary) Stocks
Direct competitors include global medical device and diagnostics peers MDT, BDX, and SYK. All are groups with broad medical device portfolios and global sales and service networks. Related names include analytical instruments and diagnostics peers TMO, DHR, and A, which tend to move in tandem across healthcare sector capital spending and R&D cycles.
| 종목 | 회사명 | 가격 | 등락 | 시총 | PER | PBR | ROE | 배당률 |
|---|---|---|---|---|---|---|---|---|
| MDT | Medtronic Plc | $85.71 | -2.1% | $109.7B | 23.0 | 2.2 | 9.85% | 3.38% |
| BDX | Becton Dickinson & Co | $165.45 | -1.8% | $45.6B | 42.0 | 1.9 | 5.72% | 2.37% |
| SYK | Stryker Corp | $348.04 | -1.2% | $133.4B | 40.3 | 5.8 | 15.2% | 1.01% |
| 종목 | 회사명 | 가격 | 등락 | 시총 | PER | PBR | ROE | 배당률 |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific Inc | $576.77 | +0.1% | $214.3B | 31.0 | 4.1 | 13.53% | 0.32% |
| DHR | Danaher Corp | $196.17 | -0.2% | $137.9B | 34.8 | 2.6 | 7.61% | 0.73% |
| A | Agilent Technologies Inc | $138.71 | -1.1% | $39.2B | 27.9 | 5.5 | 21.33% | 0.74% |
✅ GE HealthCare Investor Checkpoints
When reviewing GE HealthCare, it is important to look at the global hospital capital investment cycle, the China healthcare market recovery, and the expansion of AI-based imaging diagnostic solutions together.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| 📈 Quarterly Revenue Trends | Review revenue trends by segment: medical imaging, advanced visualization, patient care, and contrast media | Expanding trend |
| 🌍 China Market Recovery | Observe the pace of recovery in the China healthcare market and quarterly guidance | Needs monitoring |
| 🏭 Hospital Capital Spending | Check how the global hospital capital investment cycle affects demand for imaging diagnostic equipment | Cycle recovery phase |
| 💰 Capital Returns | Confirm announcements of quarterly dividend and share buyback policies | Maintained balance |
A slowdown in global hospital capital investment could reduce demand for new imaging diagnostic equipment. Policy changes and the possibility of a delayed recovery in the China healthcare market, share competition with peer global medical device groups, and cost burdens from changes in the global supply chain and tariff environment should also be factored in.
GE HealthCare is a medical device and diagnostics stock that combines a broad medical imaging portfolio, a global sales and service network, and a recurring revenue structure. Considering the volatility of the global hospital capital spending cycle, a staggered buying approach with a medium- to long-term holding perspective is recommended.
이 글은 2026년 5월 21일 기준 정보입니다.